Preload Dependency Evaluation With Stroke Volume Variation During Alveolar Recruitment Manoeuvres

Overview

The principal aim is to assess impact of alveolar recruitment manoeuvres (ARM) on stroke volume variation, evaluated by trans-oesophageal echocardiography (TEE). These variations will be measured on preload dependency or preload independency status. The principal purpose is to determine if variations of stroke volume during standardized ARM can predict the preload dependency status.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Diagnostic
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 2016

Detailed Description

Population studied: anesthetized patients for cardiac surgery of coronary bypass. Secondary endpoints : – comparison between TEE and mini-invasive monitoring systems in accuracy of measurement of stroke volume variation during ARM. These mini-invasive systems are : Clearsight system (Edwards Lifescience) and Flotrac system (Edwards Lifescience) – Difference between pre and post-cardiopulmonary bypass status on principal purpose evaluation

Interventions

  • Other: tee measurement
  • Other: flotrac measurement
  • Other: clearsight measurement

Arms, Groups and Cohorts

  • Experimental: TEE monitory system
    • comparison between TEE and mini-invasive monitoring systems in accuracy of measurement of stroke volume variation during ARM.
  • Experimental: mini-invasive monitoring system
    • comparison between TEE and mini-invasive monitoring systems in accuracy of measurement of stroke volume variation during ARM.

Clinical Trial Outcome Measures

Primary Measures

  • Variation of stroke volume
    • Time Frame: at the beginning of cardiac surgery
    • Variation of stroke volume measured by TEE, induced by a standardized ARM, at the beginning of cardiac surgery

Secondary Measures

  • Velocity time integral (cm)
    • Time Frame: at the begining of cardiac surgery
    • Velocity time integral (cm) (TEE measurement)
  • Velocity time integral (cm)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
    • Velocity time integral (cm) (TEE measurement)
  • Velocity time integral (cm)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
    • Velocity time integral (cm) (TEE measurement)
  • Cardiac index (l/min/m2)
    • Time Frame: at the begining of cardiac surgery
    • Cardiac index (l/min/m2) (TEE measurement)
  • Cardiac index (l/min/m2)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
    • Cardiac index (l/min/m2) (TEE measurement)
  • Cardiac index (l/min/m2)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
    • Cardiac index (l/min/m2) (TEE measurement)
  • Right ventricle diameter/left ventricle diameter ratio
    • Time Frame: at the begining of cardiac surgery
    • Right ventricle diameter/left ventricle diameter ratio (TEE measurement),
  • Right ventricle diameter/left ventricle diameter ratio
    • Time Frame: After fluid challenges until patient is on a preload independency state.
    • Right ventricle diameter/left ventricle diameter ratio (TEE measurement),
  • Right ventricle diameter/left ventricle diameter ratio
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
    • Right ventricle diameter/left ventricle diameter ratio (TEE measurement),
  • E/A ratio
    • Time Frame: at the begining of cardiac surgery
    • E/A ratio (TEE measurement)
  • E/A ratio
    • Time Frame: After fluid challenges until patient is on a preload independency state.
    • E/A ratio (TEE measurement)
  • E/A ratio
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
    • E/A ratio (TEE measurement)
  • Sus-hepatic vein Doppler profile
    • Time Frame: at the begining of cardiac surgery
    • Sus-hepatic vein Doppler profile (TEE measurement)
  • Sus-hepatic vein Doppler profile
    • Time Frame: After fluid challenges until patient is on a preload independency state.
    • Sus-hepatic vein Doppler profile (TEE measurement)
  • Sus-hepatic vein Doppler profile
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
    • Sus-hepatic vein Doppler profile (TEE measurement)
  • Invasive arterial pressure (mmHg)
    • Time Frame: at the begining of cardiac surgery
  • Invasive arterial pressure (mmHg)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Invasive arterial pressure (mmHg)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Heart rate (pulse/min)
    • Time Frame: at the begining of cardiac surgery
  • Heart rate (pulse/min)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Heart rate (pulse/min)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Expired CO2 (mmHg)
    • Time Frame: at the begining of cardiac surgery
  • Expired CO2 (mmHg)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Expired CO2 (mmHg)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Central venous pressure (mmHg)
    • Time Frame: at the begining of cardiac surgery
  • Central venous pressure (mmHg)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Central venous pressure (mmHg)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Pulse pressure variation (%)
    • Time Frame: at the begining of cardiac surgery
  • Pulse pressure variation (%)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Pulse pressure variation (%)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Perfusion index (pulsoxymeter)
    • Time Frame: at the begining of cardiac surgery
  • Perfusion index (pulsoxymeter)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Perfusion index (pulsoxymeter)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Stroke volume (ml) (Flotrac measurement)
    • Time Frame: at the begining of cardiac surgery
  • Stroke volume (ml) (Flotrac measurement)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Stroke volume (ml) (Flotrac measurement)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Stroke volume variation (%) (Flotrac measurement)
    • Time Frame: at the begining of cardiac surgery
  • Stroke volume variation (%) (Flotrac measurement)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Stroke volume variation (%) (Flotrac measurement)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Cardiac index (l/min/m2) (Flotrac measurement)
    • Time Frame: at the begining of cardiac surgery
  • Cardiac index (l/min/m2) (Flotrac measurement)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Cardiac index (l/min/m2) (Flotrac measurement)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Pulse pressure variation (%) (Flotrac measurement)
    • Time Frame: at the begining of cardiac surgery
  • Pulse pressure variation (%) (Flotrac measurement)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Pulse pressure variation (%) (Flotrac measurement)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Arterial pressure (mmHg) (Flotrac measurement)
    • Time Frame: at the begining of cardiac surgery
  • Arterial pressure (mmHg) (Flotrac measurement)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Arterial pressure (mmHg) (Flotrac measurement)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Stroke volume (ml) (Clearsight measurement)
    • Time Frame: at the begining of cardiac surgery
  • Stroke volume (ml) (Clearsight measurement)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Stroke volume (ml) (Clearsight measurement)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Stroke volume variation (%) (Clearsight measurement)
    • Time Frame: at the begining of cardiac surgery
  • Stroke volume variation (%) (Clearsight measurement)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Stroke volume variation (%) (Clearsight measurement)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Cardiac index (l/min/m2) (Clearsight measurement)
    • Time Frame: at the begining of cardiac surgery
  • Cardiac index (l/min/m2) (Clearsight measurement)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Cardiac index (l/min/m2) (Clearsight measurement)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Pulse pressure variation (%) (Clearsight measurement)
    • Time Frame: at the begining of cardiac surgery
  • Pulse pressure variation (%) (Clearsight measurement)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Pulse pressure variation (%) (Clearsight measurement)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Arterial pressure (mmHg) (Clearsight measurement)
    • Time Frame: at the begining of cardiac surgery
  • Arterial pressure (mmHg) (Clearsight measurement)
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Arterial pressure (mmHg) (Clearsight measurement)
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed
  • Near infrared spectroscopy : Cerebral SrO2
    • Time Frame: at the begining of cardiac surgery
  • Near infrared spectroscopy : Cerebral SrO2
    • Time Frame: After fluid challenges until patient is on a preload independency state.
  • Near infrared spectroscopy : Cerebral SrO2
    • Time Frame: After the cardiopulmonary bypass period, when sternotomy will be closed

Participating in This Clinical Trial

Inclusion Criteria

  • Adult patient Undergoing a surgical procedure of coronary artery bypass, with cardiopulmonary bypass Written consent collected Exclusion Criteria:

  • Emergency case – Pericardial effusion – Aortic or mitral valvulopathy – Contraindication for : TEE, alveolar recruitment manoeuvre (emphysema, pneumothorax, hemodynamic instability), Ringer Lactate solution infusion – Bad echogenicity – Patient refusal to participate to the study – No health insurance

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Clermont-Ferrand
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.